Navigation Links
Pharmion's Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
Date:11/9/2007

Interim analysis of Phase 2 clinical data presented at the 2007

Chemotherapy Foundation Symposium

BOULDER, Colo., Nov. 9 /PRNewswire-FirstCall/ -- Pharmion Corporation (Nasdaq: PHRM) today released interim findings from its Phase 2 trial of Amrubicin in second-line chemo-sensitive small cell lung cancer (SCLC). Amrubicin, the company's third-generation synthetic anthracycline, is a potent topoisomerase II inhibitor currently in development for the treatment of SCLC. These findings indicate favorable interim results in terms of response rate and survival for Amrubicin in second-line treatment of small-cell lung cancer patients with extensive disease (ED) SCLC. The early results of this study were presented at the 2007 Chemotherapy Foundation Symposium today in New York City.

"Treatment options for second-line SCLC are limited and preliminary data from the US-based Phase 2 sensitive SCLC trial indicate that Amrubicin may provide a new option for SCLC patients who desperately need more treatment choices," said principal investigator Robert M. Jotte, MD, PhD, Medical Director of the Lung Cancer Clinic of the Rockies, Developmental Co-Chair USON Lung Committee. "As we near completion of the Phase 2 trial, we hope that accrual to the Phase 3 trial will be rapid and confirm the results of the US Phase 2 trial and similar trials in Japan."

The trial presented today compares Amrubicin and topotecan in patients with ED-SCLC that initially responded to first-line platinum-based therapy but whose disease recurred or progressed at least 90 days after completion of first-line treatment (sensitive SCLC). Study participants are randomized in a 2:1 ratio to receive either IV Amrubicin (40mg/
'/>"/>

SOURCE Pharmion Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Pharmion Initiates Pivotal Phase 3 Study of Amrubicin in Small Cell Lung Cancer
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Study Shows Combination Therapy Incorporating AVODART(R) and Tamsulosin Provides Continuous Symptom Improvement Over 2 Years
4. Largest Study to Date Shows Significant Reductions in Risks of Blood Clots and Reintervention With CYPHER(R) Sirolimus-eluting Coronary Stent Compared to Taxus Stent
5. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
6. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
7. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
8. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
9. Feeling Anxious or Distracted? New Research Shows a Cup of Tea Could Help
10. New Study Shows Once-Monthly Boniva(R) is as Clinically Effective as Once-Weekly Fosamax(R) at Increasing Bone Mineral Density in Postmenopausal Women With Osteoporosis
11. Study Shows Vasopressin Receptor Antagonist VAPRISOL(R) (Conivaptan Hydrochloride Injection) Significantly Increased Serum Sodium Concentration in Patients with Euvolemic & Hypervolemic Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... , June 2, 2015  ErgoNurse, the leader in bedside ... healthcare products in the United States , ... home, long-term care and skilled nursing markets. ... Thousands ... to fully take advantage of the ErgoNurse products to stop ...
(Date:6/2/2015)... , June 2, 2015  Integrated Service Solutions, Inc. ("the Company") announced today they are expanding their reach nationally by ... ... ... ... ...
(Date:6/2/2015)... Today AmerisourceBergen, a global healthcare solutions leader, ... Olive Branch, MS ; ... . The facilities will operate within AmerisourceBergen,s existing ... increase supply chain efficiency and enhance patient care. ... ongoing investments, more than $1 billion over the last ...
Breaking Medicine Technology:ErgoNurse and Briggs Healthcare Positioned to Completely Eliminate the Unnecessary Cost of Healthcare-Related Back Injuries 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4AmerisourceBergen to Build Three New Distribution Centers 2
... 14, 2011 LifeVantage Corporation (OTCBB: LFVN), the ... revenue for its third fiscal quarter of 2011 of approximately ... or 35% over net revenue of $7.4 million for the ... an approximate $7.3 million or 270% increase in net revenue ...
... CITY, Iowa, April 14, 2011 Ron Van ... Natural Science , announced that research conducted at Iowa ... in DiaGel eliminates bacteria on contact. ... microdilution testing, disk diffusion, and traditional microbiological plating.  Through ...
Cached Medicine Technology:LifeVantage Announces Preliminary Third Quarter 2011 Revenue 2Van Beek Natural Science's Patented Active Compound in DiaGel Offers one Dose Natural Cure for Pet Bacterial Diarrhea 2
(Date:6/2/2015)... Health Management, LLC, a provider of outcome data, aftercare ... announced today that Jared Smith has joined the company ... responsible for developing and implementing a marketing strategy to ... products and initiatives. , Prior to joining MAP, Mr. ... Irving, Texas, where he was responsible for developing and ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 ... the opening of Surrey’s first fertility clinic. ... boasts a diverse, young community, with one ... http://www.theglobeandmail.com/news/british-columbia/four-reasons-bcs-fastest-growing-city-is-a-political-powerhouse/article21408253/ , Until now patients from ... had to come into Vancouver or Burnaby ...
(Date:6/2/2015)... Though almost the entire Park family was born ... rule their lives. Organizing and hosting the June 14 event ... to the fullest and spreading awareness of HHT. , “I've ... won't live my life in a bubble because something bad ... is to look back on your life with regret because ...
(Date:6/2/2015)... 2015 CRN International has been named a ... Employment , a Connecticut state program that takes active steps ... them at appropriate companies. , Platform to Employment is being ... Connecticut Department of Labor. CRN, a 40-year-old radio marketing company ... is being recognized for its “hard work and dedication.” , ...
(Date:6/2/2015)... NC (PRWEB) June 02, 2015 ... training and compliance solutions for the healthcare market, ... The Arc to offer 10 complimentary courses relating ... provide public safety professionals with additional resources to ... Safety professionals are often the first responders to ...
Breaking Medicine News(10 mins):Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:Olive Fertility Centre Opens First Fertility Clinic in Surrey BC 2Health News:Family brings awareness to genetic disease at first Memphis walk 2Health News:CRN Named Company Partner of the Year by CT Employment Program 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 2Health News:Relias Learning Partners with Behavioral Health and Developmental Disabilities Leaders to Offer Complimentary Resources to Public Safety Professionals 3
... biological and genetics-based explanation for the causes of anorexia ... for their illness than those given a sociocultural explanation, ... found. , This is a potentially important finding, said ... wider dissemination of information about the biological and genetic ...
... /Xinhua-PRNewswire/ -- Sundia MediTech,(Shanghai) Company recently announced a welcome ... Zhu and Dr. Shu Gao. Dr. Zhu is appointed ... as the Vice,President in charge of Chemical Synthesis business., ... his college,education in chemistry in Nanjing University in China. ...
... PPD, Inc. (Nasdaq:,PPDI) will release its fourth quarter and ... the market closes. The earnings,release will be available on ... PR Newswire., On Thursday, February 7, 2008, at ... and audio webcast to discuss financial results and the,overall ...
... HIV Rates; Governor Should Cut,Bureaucracy, Corporate Loopholes, ... today urged California Governor Arnold Schwarzenegger to,reconsider and ... AIDS services,that will reduce and threaten vital lifesaving ... he seeks to close a $14 billion,deficit in ...
... Commends CMS for Setting Date but Fear that Program ... Jan. 10 The Power Mobility,Coalition (PMC) today applauded ... a date certain when all Medicare DMEPOS,suppliers need to ... to two years for the requirement to be fully ...
... antiviral drugs fail , , THURSDAY, Jan. 10 (HealthDay News) ... that help HIV propagate, creating hope for new treatments ... a technique called RNA interference to screen thousands of ... the study published online Jan. 10 in Science ...
Cached Medicine News:Health News:People with anorexia less likely to be blamed when biology, genetics explained 2Health News:People with anorexia less likely to be blamed when biology, genetics explained 3Health News:CRO Company Sundia Welcomes New Members to Its Executive Team 2Health News:PPD Announces Fourth Quarter and Year-End 2007 Earnings Release, Webcast and Conference Call 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 2Health News:AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' 3Health News:Mandatory Accreditation Delayed Until September 2009 2Health News:New Proteins That Help HIV Grow Identified 2
The interface spatula can be used when irregular interface adherence occurs. By beginning at the point of a dissected edge and sweeping in uniplanar motion towards the area of adherence, the flap can...
Duckbilled spatula designed to enter a side-port stab incision with tip broad enough to efficiently manipulate the lens nucleus in the anterior chamber. Spatula is useful for rotating and cracking th...
Ideal for bimanual phaco procedure. 0.25 mm by 10 mm long blade. Round knurled handle with polished finish....
1 mm wide by 28 mm long sterling silver blade. Flat serrated handle with polished finish....
Medicine Products: